Abstract

Compounded Medications and Probiotics for Irritable Bowel Syndrome

Author(s): Narváez Katherine Rivera, Thompson Tara

Issue: Sep/Oct 2022 - Volume 26, Number 5

Page(s): 378-384

Download in electronic PDF format for $75

Abstract

Studies have found that the microflora composition of individuals with irritable bowel syndrome and ulcerative colitis differ from those of healthy individuals. Some findings suggest a decrease in beneficial bacteria populations and an increase in pathogenic bacteria populations or a higher abundance of bacteria overall (known as small intestinal bacterial overgrowth in these populations). Pharmaceutical compounders are able to formulate medications that are not available commercially that may provide a more targeted therapy for the treatment of irritable bowel syndrome or ulcerative colitis, or they can provide doses that may otherwise be difficult to achieve with commercially available products. This article discusses these two maladies and the important role of pharmaceutical compounding in their treatment options.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2022 Pg. 378-384	Compounded Medications and Probiotics for Irritable Bowel Syndrome Author(s): Narváez Katherine Rivera, Thompson Tara
May/Jun 2006 Pg. 195-200	Probiotic Therapy, Part 2: Clinical Perspectives Author(s): Vail Jane
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2000 Pg. 349	Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases Author(s): Hinze John, Mahan Tracy
Mar/Apr 2006 Pg. 107-111	Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives Author(s): Vail Jane
Jan/Feb 2003 Pg. 27-29	Equine Cushing’s Syndrome Author(s): Vail Jane
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
May/Jun 2019 Pg. 234	Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2002 Pg. 185	Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel Author(s): Worthen Dennis B
May/Jun 2019 Pg. 192-199	Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Author(s): Riepl Mike
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Mar/Apr 2005 Pg. 93	Book Review: Bacteria for Breakfast: Probiotics for Good Health Author(s): Reed-Kane Dana
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2013 Pg. 380-383	Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Author(s): McElhiney Linda F
Jan/Feb 2005 Pg. 62	Amitriptyline Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2007 Pg. 187-192	Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Author(s): Vail Jane
Mar/Apr 2016 Pg. 155-158	Utilization of Compounded Medications in an Oral Medicine Practice Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael